Post-translational modifications of EMT transcriptional factors in cancer metastasis

被引:12
|
作者
Chang, Rui [2 ]
Zhang, Peng [1 ]
You, Jiacong [2 ]
机构
[1] Tianjin Med Univ, Gen Hosp, Dept Cardiothorac Surg, Tianjin 300052, Peoples R China
[2] Tianjin Med Univ, Gen Hosp, Tianjin Lung Canc Inst, Tianjin Key Lab Lung Canc Metastasis & Tumor Micr, Tianjin 300052, Peoples R China
来源
OPEN LIFE SCIENCES | 2016年 / 11卷 / 01期
关键词
EMT; acetylation; phosphorylation; transcriptional factor; EPITHELIAL-MESENCHYMAL TRANSITION; E-CADHERIN EXPRESSION; BREAST-CANCER; HISTONE DEACETYLASE; GSK-3-BETA-MEDIATED PHOSPHORYLATION; LUNG-CANCER; DNA-DAMAGE; SNAIL; PROMOTES; CELLS;
D O I
10.1515/biol-2016-0033
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Metastasis is an important reason for death of cancer patients which characterized as the formation of secondary cancers at distant sites. Epithelial-mesenchymal transition (EMT) is a dynamic process that appear to facilitate tumor metastasis in various cancers by switching epithelial cells into mesenchymal properties. Although previous investigation suggested a key role of EMT transcriptional factors in suppression of E-cadherin, the association of these factors with other cellular regulators in cancer metastasis need to be fully elucidated. Post-translational modifications (PTMs), such as acetylation and phosphorylation, have emerged as an important mechanism to modulate biological behavior of substrate proteins. In this review, we summarized protein modification and subsequent function changes of Snail, Twist and ZEB, as well as their influence on tumor progression. Acetylation of EMT transcriptional factors usually cause nuclear localization and/or protein stabilization thus contribute to E-cadherin repression. Besides, Twist and ZEB were phosphorylated by diverse kinases to promote metastasis in many cancers, while Snail was negatively regulated by phosphorylation to degradation. Then, the potential of therapy for metastasis by targeting PTMs-involved regulation of EMT transcriptional factors were discussed.
引用
收藏
页码:237 / 243
页数:7
相关论文
共 50 条
  • [31] Targeting post-translational modifications of histones for cancer therapy
    Hsu, Y-C.
    Hsieh, Y-H.
    Liao, C-C.
    Chong, L-W.
    Lee, C-Y.
    Yu, Y-L.
    Chou, R-H.
    CELLULAR AND MOLECULAR BIOLOGY, 2015, 61 (06) : 69 - 84
  • [32] Regulation of HNRNP family by post-translational modifications in cancer
    Li, Bohao
    Wen, Mingxin
    Gao, Fei
    Wang, Yunshan
    Wei, Guangwei
    Duan, Yangmiao
    CELL DEATH DISCOVERY, 2024, 10 (01)
  • [33] Editorial: The role of post-translational modifications in cancer biology
    Srivastava, Swati
    Tripathi, Anurag
    Trivedi, Arun Kumar
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [34] Regulation of ovarian cancer by protein post-translational modifications
    Zhu, Qiugang
    Zhou, Huimin
    Xie, Feiting
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [35] Post-Translational Modifications That Drive Prostate Cancer Progression
    Samarzija, Ivana
    BIOMOLECULES, 2021, 11 (02) : 1 - 44
  • [36] Protein Post-translational Modifications in Head and Neck Cancer
    Zhang, Hongbo
    Han, Wei
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [37] Post-translational modifications and immune responses in liver cancer
    Wang, You-Wei
    Zuo, Jia-Chen
    Chen, Chong
    Li, Xiao-Hong
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [38] Post-translational modifications on mitochondrial metabolic enzymes in cancer
    Peng, Yunhua
    Liu, Huadong
    Liu, Jiankang
    Long, Jiangang
    FREE RADICAL BIOLOGY AND MEDICINE, 2022, 179 : 11 - 23
  • [39] Post-translational modifications of EZH2 in cancer
    Li, Zhongwei
    Li, Minle
    Wang, Diandian
    Hou, Pingfu
    Chen, Xintian
    Chu, Sufang
    Chai, Dafei
    Zheng, Junnian
    Bai, Jin
    CELL AND BIOSCIENCE, 2020, 10 (01):
  • [40] Post-translational and transcriptional modifications induced by hyperthermia or paclitaxel treatment of human lung cancer cells
    Inoue, S
    Eldin, AES
    Tsukamoto, S
    Tsuda, M
    Omoteyama, K
    Hassan, M
    CYTOMETRY PART A, 2004, 59A (01): : 48 - 48